Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report

Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease caused by reactivation of the human polyomavirus 2 (HPyV-2). PML is associated with a high morbidity and mortality rate and there is currently no standard curative therapy. We report short-term immunologic response and long-...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoff, Fieke W., Rolwes, John, Hardeman, Paula A., Perkins, Molly, Major, Eugene O., Douek, Daniel, Collins, Robert H., Greenberg, Benjamin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563476/
https://www.ncbi.nlm.nih.gov/pubmed/37822572
http://dx.doi.org/10.1177/20406207231201721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563476/
https://www.ncbi.nlm.nih.gov/pubmed/37822572
http://dx.doi.org/10.1177/20406207231201721

Ejemplares similares